Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Interest Income | 51,822 | 53,987 | 52,866 | 50,579 | 47,878 |
| Interest Expense | 31,549 | 33,927 | 32,525 | 30,598 | 28,494 |
| Interest Income (Net of Interest Expense) | 20,273 | 20,060 | 20,341 | 19,981 | 19,384 |
| Non-Interest Income | 4,262 | 3,744 | 3,581 | 3,793 | 3,370 |
| Sales | 24,535 | 23,804 | 23,922 | 23,774 | 22,754 |
| Credit Losses Provision | 1,400 | 1,300 | 1,100 | 1,100 | 1,100 |
| Non Interest Expenses | 17,604 | 16,952 | 17,307 | 17,315 | 16,394 |
| Pre-tax Income | 5,531 | 5,552 | 5,515 | 5,359 | 5,260 |
| Income Tax | 1,946 | 2,054 | 2,050 | 1,983 | 1,946 |
| Other Income | 37,080 | 39,479 | 38,040 | 35,957 | 33,754 |
| Net Income | $3,585 | $3,498 | $3,465 | $3,376 | $3,314 |
| EPS Basic Continuous Ops | 12.05 | 11.76 | 11.65 | 11.35 | 11.15 |
| EPS Basic Total Ops | 11.96 | 12.03 | 11.53 | 11.38 | 11.08 |
| EPS Diluted Continuous Ops | 11.92 | 11.62 | 11.62 | 11.32 | 11.12 |
| EPS Diluted Total Ops | 11.96 | 11.67 | 11.53 | 11.38 | 11.08 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |